Quick Dispatch:
Your soul trial oral semaglutide cardiovascular outcomes results 2025 nejm The SOUL Study orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your soul trial oral semaglutide cardiovascular outcomes results 2025 nejm The SOUL Study ships.
Need Help?
Questions about soul trial oral semaglutide cardiovascular outcomes results 2025 nejm The SOUL Study, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for soul trial oral semaglutide cardiovascular outcomes results 2025 nejm The SOUL Study in your area.
💥Soul study group recently shared the result of their study :✔️ Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes @NEJM 🟡 n=9650 🟡 42.4 %had history of CKD 🟡 Majority
28.03
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
25.71
Trial Scorecard: SOUL
26.95
Heart disease is the #1 cause of death in type 2 diabetes — and for the first time, an oral GLP-1 drug has been proven to reduce major cardiovascular events The SOUL
26.91
Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease
20.81
Frontiers
29.23
SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with
25.11
